A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF AJMODADI VATAK WITH AND WITHOUT DWIPANCHMOOLADI NIRUHA BASTI IN THE MANAGEMENT OF AMAVATA WITH SPECIAL REFERENCE TO RHEUMATOID ARTHRITIS
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
The total of 60 patients will be selected who are between age group of 30 to 60 years of either sex who are diagnosed with Amavata on the basis of sign and symptoms. Patients will be divided into two groups (Trial Group A and Trial Group B). Group A will be intervene with Dwipanchmooladi Niruha Basti along with oral administration of Ajmodadi Vatak and Group B will be intervene with oral administration of Ajmodadi Vatak and conduct a clinical study - To evaluate the efficacy of Ajmodadi Vatak in the management of Amavata w.s.r to Rheumatoid Arthritis. • To evaluate the combined efficacy of Dwipanchmooladi Niruha Basti with oral administration of Ajmodadi Vatak in the management of Amavata. • To compare the efficacy of Ajmodadi Vatak with and without Dwipanchmooladi Niruha Basti in the management of Amavata w.s.r. to Rheumatoid Arthritis
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Subjects fulfilling the 2010 EULAR/ACR revised criteria of Amavata (Rheumatoid Arthritis).
- •Subjects fit for Basti.
- •Subjects aged between 30 to 60 years of either sex.
- •Subjects with controlled Hypertension & Diabetes.
- •Subjects willing to participate in study.
排除标准
- •1.Subjects having Upadrava and Arista laxana 2.Amavata associated with severe complicated diseases like Diabetes mellitus, cardiac disease, tuberculosis, AIDS.
- •Subjects with severe deformities, severe ankylosed joints, septic arthritis and gouty arthritis etc 4.Pregnant women & lactating women.
研究者
Dr Himani Bhardwaj
Department Of Panchakarma